Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines by Sherry, L, Bahar, MW, Porta, C, Fox, H, Grehan, K, Nasta, V, Duyvesteyn, HME, De Colibus, L, Marsian, J, Murdoch, I, Ponndorf, D, Kim, S, Shah, S, Carlyle, S, Swanson, JJ, Matthews, S, Nicol, C, Lomonossoff, GP, Macadam, AJ, Fry, EE, Stuart, DI, Stonehouse, NJ, Rowlands, DJ

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy by Ragonnet-Cronin, M, Nutalai, R, Huo, J, Dijokaite-Guraliuc, A, Das, R, Tuekprakhon, A, Supasa, P, Liu, C, Selvaraj, M, Groves, N, Hartman, H, Ellaby, N, Mark Sutton, J, Bahar, MW, Zhou, D, Fry, E, Ren, J, Brown, C, Klenerman, P, Dunachie, SJ, Mongkolsapaya, J, Hopkins, S, Chand, M, Stuart, DI, Screaton, GR, Rokadiya, S